<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03544138</url>
  </required_header>
  <id_info>
    <org_study_id>Preceptis Pivotal</org_study_id>
    <nct_id>NCT03544138</nct_id>
  </id_info>
  <brief_title>In-Office Study of the Hummingbird® in Children 2-21 Years Old</brief_title>
  <official_title>Pivotal Study of the Preceptis Medical Inc. Hummingbird™ Tympanostomy Tube System (H-TTS) in the Otolaryngology Clinic: A Non-Significant Risk Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Preceptis Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Preceptis Medical, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the safety and performance of the Hummingbird® for
      the placement of ear tubes in children 2-21 undergoing tympanostomy tube placement in an
      otolaryngology clinic using local anesthetic.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Hummingbird Tympanostomy Tube System (H-TTS) is intended to deliver a tympanostomy tube
      (also referred to as a ventilation tube) through the tympanic membrane of the patient and is
      indicated to be used in office settings for children 6-24 months old. The H-TTS is intended
      to deliver a tympanostomy tube through the tympanic membrane (TM) of the patient. It combines
      the separate functions of creating a myringotomy, and positioning and placing a ventilation
      tube across the TM.

      The Hummingbird Tympanostomy Tube System (H-TTS) is a disposable surgical tool designed to
      deliver a tympanostomy tube (&quot;ear tube&quot;) into the tympanic membrane of patients during a
      tympanostomy tube placement procedure. More than 1,000,000 ear tubes are inserted annually in
      the US, making it one of the most common surgical procedures performed in children.

      Preceptis Medical, Inc. has developed the H-TTS to reduce trauma, pain, and risk to the
      patient while reducing the overall surgical procedure time. The H-TTS integrates the multiple
      surgical instruments necessary for current surgical procedure into a single, one-pass device.
      The H-TTS creates an incision in the tympanic membrane (&quot;ear drum&quot;) and inserts a
      tympanostomy tube with the push of a lever. Thus, the H-TTS allows placement of a
      tympanostomy tube with a single pass down the ear canal. The ear tube used with the H-TTS is
      a standard, commercially available tympanostomy tube. The H-TTS has been cleared by the FDA
      for use in adults in all settings, for children in a hospital or ASC setting under both
      general anesthesia and moderate (conscious) sedation and in an office setting for children
      6-24 months old.

      The study is a continuation of a multi-site, prospective, treatment-only study of the H-TTS
      in children ages 2-21 years old. The study is no longer recruiting children ages 6-24 months
      due to receiving FDA clearance in this age group. Enrollment in the study at each site will
      begin after receipt of Institutional Review Board (IRB) approval. 60 to 80 patients will be
      included at 3-10 clinical sites.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 24, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The rate of procedural AEs, and the rates for each specific type of event</measure>
    <time_frame>Intra-Procedure</time_frame>
    <description>The rate of procedural AEs, and the rates for each specific type of event, will be estimated.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Successful delivery of the tympanostomy tube by the H-TTS</measure>
    <time_frame>Intra-Procedure</time_frame>
    <description>Efficacy evaluation will consist of determining whether the H-TTS device successfully delivers the tympanostomy tube across the tympanic membrane.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Ear Infection</condition>
  <condition>Otitis Media</condition>
  <arm_group>
    <arm_group_label>Hummingbird Tympanostomy Tube System (H-TTS)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The Hummingbird Tympanostomy Tube System (H-TTS) is a disposable surgical tool designed to deliver a tympanostomy tube (&quot;ear tube&quot;) into the tympanic membrane of patients during a tympanostomy tube placement procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hummingbird Tympanostomy Tube System (H-TTS)</intervention_name>
    <description>The H-TTS is intended to deliver a tympanostomy tube through the tympanic membrane of a patient during a tympanostomy procedure.</description>
    <arm_group_label>Hummingbird Tympanostomy Tube System (H-TTS)</arm_group_label>
    <other_name>H-TTS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled to undergo tympanostomy tube insertion in the clinic.

          -  Children 2 to 21 years old

          -  Signed parental consent, and child assent documents as applicable.

          -  Parent is fluent in English.

        Exclusion Criteria:

          -  Any condition that, in the opinion of the investigator, may place the subject at
             greater risk (e.g., child with developmental delay).

          -  Anatomy precludes sufficient visualization and access to the tympanic membrane.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nicole LaSota, BA</last_name>
    <phone>612-900-5441</phone>
    <email>clinical@preceptismedical.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Steve Anderson</last_name>
    <phone>763-568-7809</phone>
    <email>steve@preceptismedical.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Care Foundation</name>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <zip>90211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gene Liu, MD</last_name>
      <phone>310-423-1220</phone>
      <email>LiuGC@csmns.org</email>
    </contact>
    <investigator>
      <last_name>Gene Liu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frank Rimell, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Ear Nose Throat &amp; Allergy</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32835</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabel Opio</last_name>
      <phone>407-253-1000</phone>
      <phone_ext>107</phone_ext>
      <email>iiopio@childrenentdocs.com</email>
    </contact>
    <investigator>
      <last_name>James Kosko, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HealthPartners Institute</name>
      <address>
        <city>Bloomington</city>
        <state>Minnesota</state>
        <zip>55425-4516</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kyra Wicklund</last_name>
      <phone>651-254-5303</phone>
      <email>Kyra.E.Wicklund@HealthPartners.Com</email>
    </contact>
    <contact_backup>
      <last_name>Jenny Koops</last_name>
      <phone>651-254-5316</phone>
      <email>Jenny.J.Koops@HealthPartners.Com</email>
    </contact_backup>
    <investigator>
      <last_name>Chris Hilton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Derek Schmidt, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Tombers, RN</last_name>
      <phone>507-538-1392</phone>
      <phone_ext>2</phone_ext>
      <email>tombers.nicole@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Shelagh Cofer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Cloud Ear, Nose &amp; Throat</name>
      <address>
        <city>Saint Cloud</city>
        <state>Minnesota</state>
        <zip>56303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ted Truitt, MD</last_name>
      <phone>320-252-0233</phone>
      <email>ttruitt@stcloudent.com</email>
    </contact>
    <investigator>
      <last_name>Theodore Truitt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Park Nicollet</name>
      <address>
        <city>Saint Louis Park</city>
        <state>Minnesota</state>
        <zip>55416</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kyra Wicklund</last_name>
      <phone>651-254-5303</phone>
      <email>Kyra.E.Wicklund@HealthPartners.com</email>
    </contact>
    <contact_backup>
      <last_name>Jenny Koops</last_name>
      <phone>651-254-5316</phone>
      <email>Jenny.J.Koops@HealthPartners.com</email>
    </contact_backup>
    <investigator>
      <last_name>Sandra Skovlund, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Grace Nimmons, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Prairie Sinus Ear &amp; Allergy, P.C.</name>
      <address>
        <city>Bismarck</city>
        <state>North Dakota</state>
        <zip>58503-0697</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jay Raisen, MD</last_name>
      <phone>701-805-8057</phone>
      <email>jay.raisen@prairieseaclinic.com</email>
    </contact>
    <investigator>
      <last_name>Jay Raisen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah Health Sciences Center</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Carricaburu, CCRP</last_name>
      <phone>801-581-3363</phone>
      <email>martin.carricaburu@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Albert Park, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.preceptismedical.com</url>
    <description>Precepts Medical, Inc.</description>
  </link>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>May 9, 2018</study_first_submitted>
  <study_first_submitted_qc>May 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2018</study_first_posted>
  <last_update_submitted>July 22, 2020</last_update_submitted>
  <last_update_submitted_qc>July 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Otitis</mesh_term>
    <mesh_term>Otitis Media</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to make IPD available to other researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

